Myomo

Myomo, Inc. Completes Historic Initial Public Offering

Ziad2022-11-25T14:05:42-05:00Myomo, Inc., a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares of its common stock at a price to the public of $7.50 per share. Read more >>

Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?

Ziad2022-11-25T14:05:42-05:00We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Read more >>

A Conversation With Jonathan Naft, CPO

Ziad2022-11-25T14:05:42-05:00In this issue, O&P News poses five questions to Jonathan Naft, CPO. Naft is the president and founder of Geauga Rehabilitation Engineering Inc., and the vice president and general manager of Myomo Inc. He is an American Board for Certification in Orthotics, Prosthetics and Pedorthics (ABC)-certified orthotist and prosthetist. He is also an electrical engineer and biomedical engineer. Read more >>

Spotlight on: Myomo, StartHub’s Startup to Watch for May

Ziad2022-11-25T14:05:42-05:00Each month as part of StartHub Startups to Watch Program we connect with the winning company to learn more about them. The May Startup to Watch is Myomo, a Cambridge-based medical robotics company. Read more >>

Paul Gudonis, CEO of Myomo, Talks IPO Launch and its MyoPro International Potential

Ziad2022-11-25T14:05:42-05:00INN had the chance to speak with Paul Gudonis, CEO of Myomo, about its lead product and IPO launch. Read more >>

Myomo pioneering an IPO that includes small investors

Ziad2022-11-25T14:05:53-05:00You might consider it a “people’s IPO.” If the medical robotics company Myomo Inc. goes public this month, as planned, it would be among the first initial public offerings by small companies on a major stock exchange funded not just by institutions but also by small investors, who are typically locked out of such transactions. Read more >>

Myomo Hosts IPO Road Show Presentation for Investors on May 3, 2017 at 12pm EDT at BioEnterprise

Ziad2022-11-25T14:05:53-05:00Myomo, Inc., a commercial stage medical robotics company with many connections in the greater Cleveland area, will be hosting a presentation for investors interested in learning about its Initial Public Offering (IPO) on May 3, 2017 at 12pm EDT. Read more >>

Myomo Hosts NYSE MKT IPO Investor Webinar on March 28, 2017

Ziad2022-11-25T14:05:53-05:00Myomo, Inc., a commercial stage medical robotics company, announced today that it is hosting a live, interactive webinar of the Company's $15 million Reg A+ IPO investment opportunity, followed by a Q&A with Myomo CEO, Paul R. Gudonis. The investor webinar will take place on Tuesday, March 28th at 2:00pm EDT. Read more >>

Myomo, a Robotic Arm Brace Maker, Aims to Raise $15M in “Mini-IPO”

Ziad2022-11-25T14:05:53-05:00Myomo, a privately held medical device company spun out of MIT, has launched an unusually structured public offering of stock aimed at raising up to $15 million and getting the company listed on the New York Stock Exchange. Read more >>

Myomo Launches Initial Public Offering Via Jobs Act Regulation A+ With Sights Set On Historic NYSE MKT Listing

Ziad2022-11-25T14:05:54-05:00Myomo, Inc., a commercial stage medical robotics Company, today announced a Regulation A+ initial public offering that allows any investor the opportunity to invest in the Company's vision for expanded mobility for those suffering from neurological disorders and upper limb paralysis. Read more >>